… for selling products of drugmakers who failed risk-based … ’s largest supplier of generic medicines, also known as … official, representing a top pharma company based in Mumbai, “The … Tied To Non-Compliant Drugmakers, Medicine Shortages Possible Disclaimer …

… key to unlocking value-added generics, improving marketability and achieving … 3D printing and continuous manufacturing. Pharma companies are moving away from batch … is actively partnering with Indian pharmaceutical companies to help reformulate existing drug …

… the U.S. drugmaker said it expected no generic competition for its … 2023. The settlement with some generic drugmakers, which is subject to certain … sales erosion of Rinvoq from generic competitors until April 2037. J …

… reached a settlement with generic drugmakers, extending the period of … lawsuits with “all” generic manufacturers seeking to bring … agreements will keep these generics out of the domestic … typical clauses that allow generics developers to launch their …

… firm GTCR agreed to acquire generic drugmaker Zentiva Group AS from Advent …

… feat via settlements with generics manufacturers who were hopeful … the announcement. The big pharma company has a market cap … Pharmaceuticals. These are all generics companies that have filed … (FDA) approval of Rinvoq generics. Following the legal proceedings, …

… deal with a slate of generic manufacturers that waylays the … entry of Rinvoq generics until well into the … the drugmakers that have filed for FDA approval of Rinvoq generics, … their efforts to advance upadacitinib generics. Rinvoq’s composition of …

… the poster child for generic drugs, Chinese pharmaceutical companies are now quietly rising …

… litigation with generic drugmakers and should prevent generic competition for … agreement with "all generic manufacturers" challenging … The identity of the generic drugmakers was not revealed in … as potentially the year generics would launch. The …

… Wednesday issued draft recommendations for drugmakers interested in developing new non … one. It also details how drugmakers should test their experimental medicines … and often available in cheap, generic form. About one out of …